Delayed Stenting for ST-Elevation Acute Myocardial Infarction in Daily Practice: A Single-Centre Experience

被引:18
|
作者
Pascal, Julien [1 ]
Veugeois, Aurelie [2 ]
Slama, Michel [3 ,4 ]
Rahal, Saliah [4 ]
Belle, Loic [5 ]
Caussin, Christophe [2 ]
Amabile, Nicolas [2 ]
机构
[1] Ctr Hosp Le Raincy Montfermeil, Dept Cardiol, Montfermeil, France
[2] Inst Mutualiste Montsouris, Dept Cardiol, 42 Blvd Jourdan, F-75014 Paris, France
[3] CHU Antoine Beclere, Dept Cardiol, Clamart, France
[4] Ctr Marie Lannelongue, Dept Cardiol, Leplessis Robinson, France
[5] CH Annecy, Dept Cardiol, Annecy, France
关键词
PERCUTANEOUS CORONARY INTERVENTION; DRUG-ELUTING STENTS; BARE-METAL STENTS; THROMBUS ASPIRATION; PRIMARY ANGIOPLASTY; IMMEDIATE; TRIALS; THERAPY; REFLOW;
D O I
10.1016/j.cjca.2015.09.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The minimalist immediate mechanical intervention (MIMI) strategy aims to restore normal anterograde flow in the culprit artery (by using manual thrombectomy or small-sized balloon predilation) and to defer potential stent implantation. This study evaluated the applicability and midterm clinical results of the MIMI strategy for ST-elevation myocardial infarction (STEMI) management. Methods: This observational study included consecutive patients admitted for ongoing STEMI (<24 hours' evolution) at 1 institution between June 2010 and June 2013. Revascularization was performed at the physician's discretion. We compared retrospectively "intentional immediate stenting" (standard technique) and "intentional delayed stenting" (MIMI technique). Results: Twenty percent of the 279 included patients were treated with the MIMI strategy. These patients were significantly younger and were more frequently men and smokers compared with patients who underwent the standard procedure. The rate of acute reocclusion of the culprit artery related to STEMI in the MIMI group was 1.8%. Druge-luting stents were used more frequently in the MIMI group (52% vs 27% in the standard group; P < 0.001). The culprit lesion was stented less frequently in the patients treated with MIMI compared with patients in the other group (28.5% vs 9%; P < 0.001). The 1-year actuarial survival free from major adverse cardiovascular events was higher in the MIMI group than in the standard group (96.3% +/- 1.8% vs 83.8% +/- 2.5%; P = 0.01). Conclusions: The MIMI strategy can be applied in selected patients with STEMI. In our centre, this strategy is associated with less systematic culprit lesion stenting and more implantation of drug-eluting stents. However, this needs to be evaluated further in a randomized trial.
引用
收藏
页码:988 / 995
页数:8
相关论文
共 50 条
  • [21] Phaeochromocytoma mimicking acute ST-elevation myocardial infarction
    Ackfeld, Theresa
    Beuret, Hadrien
    Mosar, Francesca
    Cook, Stephane
    BMJ CASE REPORTS, 2024, 17 (12)
  • [22] Hyperkalemia Masquerading as Acute ST-Elevation Myocardial Infarction
    Barsoum, Gorgina H.
    Khan, Muhammad A.
    Asif, Talal
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01)
  • [23] Contemporary Therapy of Acute ST-Elevation Myocardial Infarction
    Armstrong, Paul W.
    TEXAS HEART INSTITUTE JOURNAL, 2009, 36 (04): : 273 - 281
  • [24] ST-Elevation Acute Myocardial Infarction in a Young Man
    Usuda, Daisuke
    Tanaka, Risa
    Suzuki, Makoto
    Takano, Hayabusa
    Hotchi, Yuta
    Shimozawa, Shintaro
    Tokunaga, Shungo
    Osugi, Ippei
    Katou, Risa
    Ito, Sakurako
    Mishima, Kentaro
    Kondo, Akihiko
    Mizuno, Keiko
    Takami, Hiroki
    Komatsu, Takayuki
    Oba, Jiro
    Nomura, Tomohisa
    Sugita, Manabu
    JOURNAL OF MEDICAL CASES, 2022, 13 (06) : 281 - 289
  • [25] A single dose of erythropoietin in ST-elevation myocardial infarction
    Voors, Adriaan A.
    Belonje, Anne M. S.
    Zijlstra, Felix
    Hillege, Hans L.
    Anker, Stefan D.
    Slart, Riemer H. J. A.
    Tio, Rene A.
    Van't Hof, Arnoud
    Jukema, J. Wouter
    Peels, Hans Otto J.
    Henriques, Jose P. S.
    ten Berg, Jurrien M.
    Vos, Jeroen
    van Gilst, Wiek H.
    van Veldhuisen, Dirk J.
    EUROPEAN HEART JOURNAL, 2010, 31 (21) : 2593 - 2600
  • [26] A single dose of erythropoietin in ST-elevation myocardial infarction
    Bergmann, Martin W.
    HERZ, 2010, 35 (06) : 424 - 424
  • [27] IN-HOSPITAL MORTALITY IN PERCUTANEOUS CORONARY STENTING OF SINGLE VERSUS MULTIPLE VESSELS IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION
    Ugoeke, Nene
    Maludum, Obiora
    Mahida, Hetavi
    Apolito, Renato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1280 - 1280
  • [28] ST-elevation does not always mean myocardial infarction: Acute myocarditis as a cause of ST-elevation
    Clemmer, J. A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 270 - 271
  • [29] External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation
    Spitzer, Ernest
    Hadorn, Susanne
    Zanchin, Thomas
    Yamaji, Kyohei
    Moschovitis, Aris
    Pilgrim, Thomas
    Stortecky, Stefan
    Juni, Peter
    Heg, Dik
    Windecker, Stephan
    Raber, Lorenz
    EUROINTERVENTION, 2016, 12 (09) : 1135 - 1143
  • [30] Trends and Clinical Outcomes in Patients Undergoing Primary Percutaneous Revascularisation for ST-Elevation Myocardial Infarction: A Single Centre Experience
    Dawson, Luke P.
    Warren, Josephine
    Mundisugih, Juan
    Nainani, Viveka
    Chan, William
    Stub, Dion
    Broughton, Archer
    Taylor, Andrew J.
    Walton, Antony
    Duffy, Stephen J.
    Shaw, James A.
    HEART LUNG AND CIRCULATION, 2018, 27 (06): : 683 - 692